• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Concentration of SARS-CoV-2 antibodies in COVID-19 recovered women

byAikansha ChawlaandAlex Chan
August 19, 2022
in Infectious Disease, Obstetrics, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. SARS-CoV-2 IgA and IgG antibodies are present in the breastmilk of COVID-19 recovered women

2. Neither presence of symptoms nor time since positive SARS-CoV-2 test were found to be independent predictors affecting antibody concentration in milk

Evidence Rating Level: 2 (Good)

Newborn infants are an at-risk population who are unable to get SARS-CoV-2 vaccines due to their immature immune systems. It is well known that passive immunity can come from maternal milk for the prevention of various diseases, and previous studies have reported human milk as a source of maternal SARS-CoV-2 antibodies. The relative concentrations of these antibodies in milk however, have not been studied. This retrospective cohort study investigated the concentrations of SARS-CoV-2 IgG and IgA in human milk and serum using Enzyme Linked ImmunoSorbent Assay (ELISA) of blood serum and human milk from patients who had recovered from COVID-19 in pregnancy and those who had COVID-19 during time of delivery. Patients had PCR confirmed coronavirus infection during pregnancy or during delivery and lactation. Women with no history of COVID-19 served as controls. All women were discharged home, with no acute symptoms of infection and with n maternal or neonatal deaths due to infection. Maternal blood and breast milk samples were collected. Former virus exposure was highly associated with the prevalence and level of anti- SARS-CoV-2 IgG and IgA antibodies in breastmilk (p <0.001), with concentrations of anti- SARS-CoV-2 IgA antibodies than IgG. No statistically significant difference between antibody levels were seen between symptomatic and asymptomatic women, additionally, no statistically significant correlation was seen between time since positive SARS-CoV-2 test and level of antibody in the timespan studied (up to 229 days). Overall, this study found that SARS-CoV-2 IgA and IgG antibodies are present in human milk in women who had COVID-19 throughout pregnancy or at time of delivery and can last up to 9 months. Future studies can be done to evaluate the protective capacity of human milk against SARS-CoV-2.

Click to read the study in BMC Pregnancy and Childbirth

Image: PD

RELATED REPORTS

Abridge drafts pediatric notes so physicians stay with the kids, not the keyboard

Evaluating scar outcomes in pediatric burn patients following skin grafting 

Trimethoprim-sulfamethoxazole during pregnancy does not reduce risk of prematurity

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: COVID-19obstetricspediatricsSARS-CoV-2
Previous Post

Upadacitinib is safe and effective for treatment of non-radiographic axial spondyloarthritis

Next Post

#VisualAbstract: Prasinezumab therapy does not affect Parkinson’s Disease progression

RelatedReports

Baby-led weaning not linked to increased choking
AI Roundup

Abridge drafts pediatric notes so physicians stay with the kids, not the keyboard

July 7, 2025
Pediatrics

Evaluating scar outcomes in pediatric burn patients following skin grafting 

June 26, 2025
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Infectious Disease

Trimethoprim-sulfamethoxazole during pregnancy does not reduce risk of prematurity

June 9, 2025
Being overweight and obese associated with increased incidence of chronic kidney disease
Chronic Disease

Worsening kidney function observed following SARS-CoV-2 infection in children

May 23, 2025
Next Post
#VisualAbstract: Prasinezumab therapy does not affect Parkinson’s Disease progression

#VisualAbstract: Prasinezumab therapy does not affect Parkinson’s Disease progression

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]

The VALENCE trial: Sofosbuvir–ribavirin for hepatitis C [Classics Series]

Quick Take: Association of Prenatal Exposure to Air Pollution with Autism Spectrum Disorder

Timing of developmental milestones varies greatly in children with autism

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
  • Mazdutide significantly reduces weight in adults with overweight or obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.